SELECXINE

SELECXINE is a biotech company in B-1101, 167, Songpa-daero, Songpa-gu, Seoul, 05855, Republic of Korea, South Korea, founded in 2018. It has raised $12.0M across 2 rounds, most recently a Series B in 2022 (est.).

Precision Immune Modulation for a Better Tomorrow

Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$12.0M
Last Round
Series BJan 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Selecxine develops therapeutic antibodies using proprietary discovery and conjugation technologies. Its Selectope platform combines phage-library generation, cell-based panning, epitope mapping, and antibody characterization to identify selective, functionally validated candidates. The company's pipeline includes an antibody-cytokine conjugate designed to amplify anti-tumor immune responses and additional antibody programs intended to selectively suppress inflammatory signaling while preserving beneficial immune biology.

Summary

It lists 1–10 employees. It has raised $12.0M in total across 2 rounds, most recently a Series B round in 2022 (est.). Investors include Stonebridge Capital, STIC Ventures and Hanwha Investment & Securities.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries B2022 (est.)

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SELECXINE on Indexed.vc
<a href="https://indexed.vc/companies/selecxine"><img src="https://indexed.vc/api/badge/company/selecxine" alt="SELECXINE on Indexed.vc" width="260" height="76" /></a>